SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...
News
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
- Ed and Linda Whitacre contribute $7 million to support health research, engineering and ...
The University of Texas at San Antonio has received a $7 million gift commitment from longtime philanthropic supporter and former AT&T CEO Ed ...
- Preoperative radiation may improve antitumor immune response in most common form of ...
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium (SABCS), held December 9–12, 2025 ...
- 'Are you married?' Why doctors ask invasive questions during treatment
(THE CONVERSATION) It's a rare occasion when my worlds of biomedical informatics and serialized lesbian melodrama fandom collide. ... San Antonio-based ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
... San Antonio Breast Cancer Symposium. Share. SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology ...